Pompano Beach Fla., June 10, 2015 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ:DSKX). The Integra over-the-counter tablet for thinning hair and improved hair health is now here. The first reveal image can be seen on this link: http://dshairclinic.com/letters/Integra.png
It is the world’s first tablet that contains Astressin-B along with a combination of other novel compounds. This product is the result of findings from DS Healthcare Group’s ongoing research on hair loss and related conditions. Astressin-B is a complex peptide that has shown in landmark research that it can reduce the effects of Corticotropin-releasing hormone (CRH) involved in the stress response. CRH is associated with many other diseases and is also believed to have a direct impact on hair health.
“We are extremely excited about this new treatment option. Integra is revolutionary and unlike anything else currently available. All other supplements are based on ordinary vitamins and minerals which have no known mechanism for efficacy. We expect strong results in markets where oral tablets are popular and expect a high clinical acceptance among doctors,” stated DS Healthcare President and CEO Daniel Khesin.
About DS Healthcare Group
DS Healthcare Group Inc. (DSKX) leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, salons and pharmacies. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
Abner Silva DS Healthcare Group 407.342.4112 Abner@DSHealthgroup.com
Source:DS Healthcare Group, Inc.